Endo International plc announced the appointment of Sharad S. Mansukani, M.D., CPE, CMCE to the company's board of directors effective immediately. The company also announced Douglas S. Ingram's decision to resign as a director from the company's board of directors effective November 6, 2017 due to his appointment as President and CEO of Sarepta Therapeutics earlier this year. Dr. Mansukani currently serves as a senior advisor to TPG Capital LP and on the board of directors of Kindred Healthcare Inc. He previously served on the board of directors of IASIS Healthcare, Surgical Care Affiliates, IMS Health Holdings Inc. and as vice chairman of the board of directors of HealthSpring Inc. as well as a strategic advisor to the board of directors of Cigna Corporation.